Emergent BioSolutions Inc (EBS)
9.60
+0.20
(+2.13%)
USD |
NYSE |
Nov 22, 11:11
Emergent BioSolutions Gross Profit Margin (Quarterly): 56.80% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 56.80% |
| June 30, 2024 | -19.35% |
| March 31, 2024 | 50.55% |
| December 31, 2023 | 31.42% |
| September 30, 2023 | 33.03% |
| June 30, 2023 | 42.47% |
| March 31, 2023 | 3.11% |
| December 31, 2022 | 31.75% |
| September 30, 2022 | 33.84% |
| June 30, 2022 | 27.87% |
| March 31, 2022 | 47.67% |
| December 31, 2021 | 67.88% |
| September 30, 2021 | 30.31% |
| June 30, 2021 | 38.78% |
| March 31, 2021 | 69.13% |
| December 31, 2020 | 67.73% |
| September 30, 2020 | 58.53% |
| June 30, 2020 | 65.02% |
| March 31, 2020 | 54.74% |
| December 31, 2019 | 60.50% |
| September 30, 2019 | 60.90% |
| June 30, 2019 | 50.15% |
| March 31, 2019 | 45.65% |
| December 31, 2018 | 53.54% |
| September 30, 2018 | 55.41% |
| Date | Value |
|---|---|
| June 30, 2018 | 58.12% |
| March 31, 2018 | 46.71% |
| December 31, 2017 | 64.99% |
| September 30, 2017 | 66.59% |
| June 30, 2017 | 56.60% |
| March 31, 2017 | 53.49% |
| December 31, 2016 | 68.05% |
| September 30, 2016 | 64.49% |
| June 30, 2016 | 49.62% |
| March 31, 2016 | 66.36% |
| December 31, 2015 | 74.50% |
| September 30, 2015 | 72.65% |
| June 30, 2015 | 70.00% |
| March 31, 2015 | 38.60% |
| December 31, 2014 | 82.75% |
| September 30, 2014 | 65.47% |
| June 30, 2014 | 60.54% |
| March 31, 2014 | 50.65% |
| December 31, 2013 | 77.33% |
| September 30, 2013 | 73.70% |
| June 30, 2013 | 74.17% |
| March 31, 2013 | 81.23% |
| December 31, 2012 | 79.62% |
| September 30, 2012 | 81.06% |
| June 30, 2012 | 75.20% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-19.35%
Minimum
Jun 2024
69.13%
Maximum
Mar 2021
42.59%
Average
45.07%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Geovax Labs Inc | -- |
| Tonix Pharmaceuticals Holding Corp | 44.90% |
| Abbott Laboratories | 55.83% |
| Insulet Corp | 69.33% |
| SIGA Technologies Inc | 53.59% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.94% |
| Return on Assets | -12.27% |
| Return on Invested Capital | -14.79% |
| Profit Margin (Quarterly) | 40.45% |
| Operating Margin (Quarterly) | 22.73% |
| Return on Net Operating Assets | -14.69% |